Multidisciplinary Healthcare for Hypothyroidism Contributions from Physicians, Nurses, and Laboratory Professionals in Saudi Arabia
DOI:
https://doi.org/10.22399/ijcesen.4029Keywords:
Hypothyroidism, multidisciplinary healthcare, physicians, nurses, laboratory professionals, Saudi ArabiaAbstract
Hypothyroidism, a common endocrine disorder characterized by insufficient production of thyroid hormones, necessitates collaborative efforts among healthcare professionals to ensure effective diagnosis, management, and patient education. In Saudi Arabia, the approach to treating hypothyroidism leverages a multidisciplinary healthcare model that includes physicians, nurses, and laboratory professionals. Physicians, particularly endocrinologists and general practitioners, play a pivotal role in diagnosing the condition through regular screenings and clinical assessments. They are also responsible for formulating treatment plans that may involve hormone replacement therapies and ongoing monitoring. Nurses contribute significantly to patient care by providing education on medication adherence, lifestyle modifications, and the importance of regular follow-ups, thus ensuring that patients are actively involved in their own health management. Laboratory professionals serve as essential members of the healthcare team by conducting comprehensive thyroid function tests that are critical for accurate diagnosis and ongoing monitoring of hypothyroidism. Their expertise enables timely and precise analysis of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels, which are crucial for adjusting treatment protocols. In the context of Saudi Arabia, where healthcare systems are continuously evolving, the collaboration among these professionals helps address the growing prevalence of thyroid disorders. Emphasizing a team-based approach not only enhances patient outcomes but also fosters an integrated healthcare system that benefits from shared knowledge and resources. The contributions of each discipline are vital, culminating in a holistic strategy that not only treats hypothyroidism but empowers patients to lead healthier lives.
References
1. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39-51.
2. Al-Jurayyan NA, Al-Herbish AS, El-Desouki MI, Al-Nuaim AA, Abo-Bakr AM, Al-Husain MA. Congenital anomalies in infants with congenital hypothyroidism: is it a coincidental or an associated finding? Hum Hered. 1997;47(1):33-37.
3. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235.
4. Al Shanqeeti SA, Alkhudairy YN, Alabdulwahed AA, Ahmed AE, Al-Adham MS, Mahmood NM. Prevalence of subclinical hypothyroidism in pregnancy in Saudi Arabia. Saudi Med J. 2018;39(3):254-260.
5. Abu-Helalah M, Alshraideh HA, Al-Sarayreh SA, Al Shawabkeh AHK, Nesheiwat A, Younes N, Al-Hader A. A cross-sectional study to assess the prevalence of adult thyroid dysfunction disorders in Jordan. Thyroid. 2019;29:1052-1059.
6. Irving SA, Vadiveloo T, Leese GP. Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS) Clin Endocrinol. 2015;82(1):136-141.
7. Alenazi SA, Abdalla SH, Mohamed HT, Balla AA, Abukanna AM. Prevalence of congenital hypothyroidism in northern border region of Kingdom of Saudi Arabia. Indian Pediatr. 2017;54(2):154-155.
8. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000;160(11):1573-1575.
9. Al-Jurayyan N, Al-Nuaim A, Redha M, El-Desouki M, Al AH, Abo AB, Al AS, Al YM, Al AD. Neonatal screening for congenital hypothyroidism in Riyadh: analysis of six year's experience. Ann Saudi Med. 1996;16(1):20-23.
10. Al Eidan E, Ur Rahman S, Al Qahtani S, Al Farhan AI, Abdulmajeed I. Prevalence of subclinical hypothyroidism in adults visiting primary health-care setting in Riyadh. J Community Hosp Internal Med Perspect. 2018;8(1):11-15.
11. Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med. 1999;130(9):750-758.
12. Chakera AJ, Pearce SH, Vaidya B. Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther. 2012;6:1-11.
13. Al-Mogbel TA. Prevalence of thyroid disorders among Saudi adults. Saudi Med J. 2012;33(2):191-194.
14. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL. 2013 ETA Guideline: management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-228.
15. Aljabri KSJ, Alnasser IM, Facharatz BS, Bokhari SA, Alshareef MA, Khan PM. The frequency of hypothyroidism in Saudi community-based hospital: A retrospective single centre study. Trends Diabetes Metab. 2019;2:1-4.
16. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003.
17. Zou M, Alzahrani AS, Al-Odaib A, Alqahtani MA, Babiker O, Al-Rijjal RA, BinEssa HA, Kattan WE, Al-Enezi AF, Al Qarni A. Molecular analysis of congenital hypothyroidism in Saudi Arabia: SLC26A7 mutation is a novel defect in thyroid dyshormonogenesis. J Clin Endocrinol Metabol. 2018;103(5):1889-1898.
18. Al-Jurayyan NA, Shaheen FI, Al-Nuaim AA, El-Desouki MI, Faiz A, Al Herbish AS, Abo Bakr AM, Al-Swailem AA, Al Mazrou YY. Congenital hypothyroidism: increased incidence in Najran province, Saudi Arabia. J Trop Pediatr. 1996;42(6):348-351.
19. Benvenga S, Di Bari F, Vita R. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine. Endocrine. 2017;56(1):138-145.
20. Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res. 2015;8(1):8.
21. Alqahtani SM. Awareness of thyroid disorders among the Saudi population. Age. 2021;20:377.
22. Faggiano A, Del Prete M, Marciello F, Marotta V, Ramundo V, Colao A. Thyroid diseases in elderly. Minerva Endocrinol. 2011;36(3):211.
23. Saudi Arabia and Gulf Thyroid Advisory Board. Protocol for management of hypothyroidism: a consensus of GCC countries. A roadmap. London: Springer; 2018.
24. Taylor PN, Eligar V, Muller I, Scholz A, Dayan C, Okosieme O. Combination thyroid hormone replacement; knowns and unknowns. Front Endocrinol (Lausanne). 2019;10:706.
25. Almuzaini A, Alshareef B, Alghamdi S, Munshy AA, Aljarallah AK, Salman SA, Alroqi KS, Alkhaldi RD. Assessment of knowledge and awareness regarding thyroid disorders among Saudi people. IJDMC. 2019;3:1070-1076.
26. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-1562.
27. American Thyroid Association. General Information. 2019.
28. De Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. 2008;29(3):195-202.
29. Cooper DS. Subclinical hypothyroidism. N Engl J Med. 2001;345(4):260-265.
30. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534.
31. Alyahya A, AlNaim A, AlBahr AW, Almansour F, Elshebiny A. Knowledge of Thyroid Disease Manifestations and Risk Factors Among Residents of the Eastern Province, Saudi Arabia. Cureus. 2021;13:e13035.
32. Almousa AIS, Alotaibi AMD. Survey of awareness of thyroid disorders among the Riyadh population, Central Region of Saudi Arabia. Egypt. J. Hosp. Med. 2018;72:4039-4044.
33. Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 2014;21:377-383.
34. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol. 2007;32:49-65.
35. Sethi B, Khandelwal D, Vyas U. A cross-sectional survey to assess knowledge, attitude, and practices in patients with hypothyroidism in India. Thyroid. Res. Pract. 2018;15:15-22.
36. Strikić Đula I, Pleić N, Babić Leko M, Gunjača I, Torlak V, Brdar D, Punda A, Polašek O, Hayward C, Zemunik T. Epidemiology of Hypothyroidism, Hyperthyroidism and Positive Thyroid Antibodies in the Croatian Population. Biology. 2022;11:394.
37. van der Spek AH, Fliers E, Boelen A. The classic pathways of thyroid hormone metabolism. Mol. Cell. Endocrinol. 2017;458:29-38.
38. Qiu Y, Hu Y, Xing Z, Fu Q, Zhu J, Su A. Birth control pills and risk of hypothyroidism: A cross-sectional study of the National Health and Nutrition Examination Survey, 2007-2012. BMJ Open. 2021;11:e046607.
39. Thyroid Foundation of Canada. About thyroid disease. 2018.
40. Randolph GW. Surgery of the Thyroid and Parathyroid Glands. Elsevier; Amsterdam, The Netherlands: 2020.
41. Mathew P, Rawla P, Fortes K. Hyperthyroidism (Nursing) StatPearls Publishing; Tampa, FL, USA: 2021.
42. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. South Afr Fam Pract. 2012;54(5):384-390.
43. La Vignera S, Vita R. Thyroid dysfunction and semen quality. Int J Immunopathol Pharmacol. 2018;32:2058738418775241.
44. La Vignera S, Vita R, Condorelli RA, Mongioi LM, Presti S, Benvenga S, Calogero AE. Impact of thyroid disease on testicular function. Endocrine. 2017;58(3):397-407.
45. Prevalence and consequences of thyroid dysfunction. In: Stone MB, Wallace RB, Committee on Medicare Coverage of Routine Thyroid Screening, eds. Medicare coverage of routine screening for thyroid dysfunction. Washington, D.C.: National Academy of Sciences; 2003. pp. 21-31.
46. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270-278.
47. Vanderpump MP, Tunbridge WMG. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 2002;12(10):839-847.
48. Knudsen N, Jørgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol. 1999;51(3):361-367.
49. Hasanato R, Mirah JA, Al-Shahrahi N, Alfulayyih N, Almutairi A, Ogailan B, Fatma S. Incidence of thyroid diseases in female Saudi adults visiting a tertiary care hospital in Riyadh. Epidemiology (Sunnyvale). 2017;7(1):1000286.
50. Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6(2):58-64.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
